Researchers tested the drug, not yet on the market, in mouse models of Lyme disease at seven-day, 14-day, and 21-day intervals and found that it eliminated the infection. For the first time, azlocillin also proved effective in killing drug-tolerant forms of B. burgdorferi in lab dishes, indicating that it may work as a therapy for lingering symptoms of Lyme disease.
Researchers plan to conduct a clinical trial.
One day… Maybe.
When can you complain about the slow response?
How many of those will there be?
And how many chemists will hold stock? Who even sells it legally?